IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion.
about
Molecular Genetic of Atopic dermatitis: An UpdateNew insights into T cells and their signature cytokines in atopic dermatitisActivated protein C: A regulator of human skin epidermal keratinocyte functionSkin barrier defects in atopic dermatitisTSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents.Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis.Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.Asymmetric stem-cell division ensures sustained keratinocyte hyperproliferation in psoriatic skin lesionsTherapeutic Effects of Erythroid Differentiation Regulator 1 on Imiquimod-Induced Psoriasis-Like Skin Inflammation.Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase.Psoriasis: rationale for targeting interleukin-17.The pathologic and clinical intersection of atopic and autoimmune disease.Cytokines and the skin barrier.Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis.Molecular biology of atopic dermatitis.Advances in the diagnosis and therapeutic management of atopic dermatitis.The role of interleukin-17A in psoriatic disease.Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasisHereditary barrier-related diseases involving the tight junction: lessons from skin and intestine.Epidermal tight junctions in health and disease.Dual Role of Act1 in Keratinocyte Differentiation and Host Defense: TRAF3IP2 Silencing Alters Keratinocyte Differentiation and Inhibits IL-17 ResponsesRole of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.Secukinumab: a promising therapeutic option in spondyloarthritis.Lipid-specific T cells and the skin.Tight junctions in skin inflammation.Secukinumab in the treatment of psoriasis: an update.The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis.Skin cancer in patients with psoriasis.IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.Risk factor-dependent dynamics of atopic dermatitis: modelling multi-scale regulation of epithelium homeostasis.Matriptase-1 expression is lost in psoriatic skin lesions and is downregulated by TNFα in vitro.Atopic Dermatitis Studies through In Vitro Models.Relationship Between Serum Interleukin-17F Level and Severity of Atopic Dermatitis in Children.Current Understanding in Pathogenesis of Atopic Dermatitis.Egr-1 is a key regulator of IL-17A-induced psoriasin upregulation in psoriasis.Filaggrin mutations are strongly associated with contact sensitization in individuals with dermatitis.The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function.Therapeutic vaccines for allergic disease.
P2860
Q26752702-F85E3119-3D78-4B4B-B99E-1D4D5FD55686Q26801199-97144060-53BB-4B6A-8018-14003F6E876CQ26830499-E9336413-D282-4F8D-A6CA-E7292EE94BD6Q30405464-C40B1AB6-E740-4EAF-B5D2-B9C58B7B7940Q33674018-83DC6354-5598-401C-AD02-CBA0CEFE3F13Q33877517-51B777ED-642E-48F0-AFA9-169C498ED9C8Q36121354-AAE361AE-E169-410A-BE4A-98535A1FDE50Q36473693-2264D08A-19E2-4597-A949-59E2A32BAE24Q36667189-CE85F16C-84F7-4117-B120-C00AF96F3FE8Q36916564-B627C9C4-3C56-45D1-A8CD-0858295B71D9Q38020227-13712194-C242-4322-83DB-D52F9AE43DEBQ38035182-BD508B95-6C60-4416-98B6-69045329D610Q38093338-B2E8509E-CDC0-47D9-8E5B-58D5C239341CQ38118781-B790C5C9-8B95-4799-B73C-48BF02BF2B52Q38203185-97742AC6-675B-4E21-B173-4FF3458C429DQ38211352-2D423157-4171-4976-A46D-54F7DC069B3DQ38217029-2D1A703D-894F-48E1-BC4D-6E8F16B5FDF3Q38237063-DC780035-9404-4383-B0DA-F936191BFE02Q38348536-AD7C13E2-E673-4533-ABEB-DDC439DBF7DEQ38403654-89080A66-093B-443F-81E1-386E4A941BF2Q38436135-E41DB9E9-6ADC-46E9-A130-3AF8A8CF4501Q38458004-CDD4987F-91F0-4821-AEB1-45C4D9612354Q38733182-4D571840-B30E-4ED3-891B-11576C5F758EQ38799600-A4938EF2-B3C5-440C-A9E4-F753DA684004Q38903129-1A6ECDCC-ACDB-4F23-B671-01B0D781E0CBQ38964257-A49B4641-77BE-4519-96E5-3CE47484E70CQ39010646-4A175496-9756-42BE-8B8E-10F40B0262BAQ39120166-618238A8-D310-411A-ABBE-A2328E162900Q39402846-2C42AA56-87B3-4D0A-B462-4CFCDE05C8B8Q39955389-DFAD2083-2FD9-4F0A-A88E-553D29FC6BEAQ40172237-586EE94E-50C8-4B47-819E-25C3E24B67ECQ40186622-A6C676AF-BE3B-4331-B425-27F2412EEF27Q40380590-CD498411-338E-4D3B-A183-094215AC1ABBQ41101918-613831BF-D42F-4F1D-9195-602DC2C63B1BQ41437618-80175E24-9B8C-4713-8ACF-168CC9D4B7E0Q41823296-B2C17990-17AC-450B-BAEB-2DE8E323505AQ44788604-5E60F609-0581-4C45-8EA3-E23B61720A42Q44949952-EB5D5815-2157-4667-8A6D-635C523587D2Q46320645-657EAC01-64AE-4155-A431-BD9AE707498AQ47100584-D0F39D78-6EC7-45EE-A560-EA5BAAD53666
P2860
IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
IL-17 downregulates filaggrin ...... ciated with cellular adhesion.
@en
type
label
IL-17 downregulates filaggrin ...... ciated with cellular adhesion.
@en
prefLabel
IL-17 downregulates filaggrin ...... ciated with cellular adhesion.
@en
P2093
P2860
P1476
IL-17 downregulates filaggrin ...... ciated with cellular adhesion.
@en
P2093
Anna L Schaupp
Graham S Ogg
Maryam Salimi
Stephen Taylor
Tess McPherson
Tharini A Selvakumar
P2860
P304
P356
10.1111/J.1600-0625.2011.01412.X
P577
2012-02-01T00:00:00Z